selected publications
-
PTH and bone material strength in hypoparathyroidism as measured by impact microindentation.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.
2019
Academic Article
GET IT
Times cited: 17 -
Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
Current osteoporosis reports.
2018
Review
GET IT
Times cited: 84 -
Robust Trabecular Microstructure in Type 2 Diabetes Revealed by Individual Trabecula Segmentation Analysis of HR-pQCT Images.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2018
Academic Article
GET IT
Times cited: 22 -
Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.
The Journal of clinical endocrinology and metabolism.
2016
Academic Article
GET IT
Times cited: 148 - Basal Insulin Use in the Non-Critical Care Setting: Is Fasting Hypoglycemia Inevitable or Preventable?. Journal of diabetes science and technology. 2014 Article GET IT
-
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 102 -
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.
Leukemia & lymphoma.
2007
Academic Article
GET IT
Times cited: 53 -
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.
Blood.
2007
Academic Article
GET IT
Times cited: 161 -
Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.
British journal of haematology.
2007
Academic Article
GET IT
Times cited: 79